drugset / Trial / NCT05642793

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

NCT05642793

Phase 2 Unknown 80 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

This is an unmasking randomized clinical trial. the main purpose of this study is to analyze whether posvitrectomy proactive use of conbercept can reduce the rate of postoperative complication in PDR patients.

Timeline

Start
2022-04-01
Primary completion
2023-09-30
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic Intravitreal